Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-335

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-335-90 (Atorvastatin 80mg 500s Container Label)

71205-335-90 (Atorvastatin 80mg 500s Container Label)
This is the label of a relabeled bottle of Atorvastatin Calcium 80mg tablets. The tablets were relabeled by Proficient Rx LP in Thousand Oaks, California with lot number 00000 and an expiration date of 00/00/00. Each film-coated tablet contains 80mg of atorvastatin calcium equivalent to atorvastatin. The tablets are coded with "MA" on one side and "4" on the other side. They are packaged in bottles of 90 tablets each and are only available by prescription. The original product ID is SA033590 and the manufacturer is MSN Laboratories Private Limited in Telangana, India. The bottle should be stored between 20°-25°C (68°-77°F) and kept out of the reach of children.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
This appears to be a graph or chart displaying the cumulative hazard and time to first primary endpoint through a four-year follow-up period. The hazard percentage is shown as 1517 and there seems to be data points represented on a time scale up to five years. Additionally, there is a hazard ratio of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001 displayed. Without more context it is difficult to provide further information.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
This is a table showing the percentage of subjects experiencing a major cardiovascular event at different time points (in years) while taking Atorvastatin at different doses (10mg and 80mg). The efficacy of Atorvastatin at reducing the risk of cardiovascular events is also shown, with a hazard ratio of 0.78 (p=0.0002) for the 80mg dose compared to placebo.*
FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.